InMed Pharmaceuticals Inc.
INM
$2.12
-$0.23-9.66%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 11.12M | 4.72M | 3.46M | 5.63M | 6.61M |
Total Receivables | 465.10K | 367.80K | 262.60K | 284.70K | 352.80K |
Inventory | 961.20K | 814.00K | 1.10M | 1.22M | 1.24M |
Prepaid Expenses | 321.70K | 507.90K | 644.00K | 148.90K | 477.70K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 12.87M | 6.41M | 5.47M | 7.28M | 8.69M |
|
|||||
Total Current Assets | 12.87M | 6.41M | 5.47M | 7.28M | 8.69M |
Net Property, Plant & Equipment | 992.20K | 1.11M | 1.23M | 1.34M | 1.25M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 1.62M | 1.66M | 1.70M | 1.74M | 1.78M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K |
Total Assets | 15.58M | 9.28M | 8.50M | 10.47M | 11.82M |
|
|||||
Total Accounts Payable | 370.10K | 559.80K | 574.60K | 449.00K | 626.20K |
Total Accrued Expenses | 1.03M | 846.20K | 784.40K | 560.60K | 986.80K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 435.50K | 429.20K | 419.70K | 424.30K | 317.80K |
Total Finance Division Other Current Liabilities | 700.00 | 3.70K | 12.30K | 2.00K | 41.00K |
Total Other Current Liabilities | 700.00 | 3.70K | 12.30K | 2.00K | 41.00K |
Total Current Liabilities | 1.84M | 1.84M | 1.79M | 1.44M | 1.97M |
|
|||||
Total Current Liabilities | 1.84M | 1.84M | 1.79M | 1.44M | 1.97M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 305.80K | 419.30K | 529.20K | 633.80K | 644.90K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.15M | 2.26M | 2.32M | 2.07M | 2.62M |
|
|||||
Common Stock & APIC | 130.54M | 122.34M | 119.38M | 119.02M | 118.15M |
Retained Earnings | -117.24M | -115.45M | -113.33M | -110.75M | -109.08M |
Treasury Stock & Other | 128.60K | 128.60K | 128.60K | 128.60K | 128.60K |
Total Common Equity | 13.43M | 7.02M | 6.18M | 8.40M | 9.21M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 13.43M | 7.02M | 6.18M | 8.40M | 9.21M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 13.43M | 7.02M | 6.18M | 8.40M | 9.21M |
|